Q2 2013

Filed Aug 19, 2013 · 10-Q · 50 days after period end · 0001144204-13-046848

Q2 2013 · 10-Q

Revenue

$20.30K

+24.6% vs Q2 2012

Net Income

-$609.15K

N/M vs Q2 2012

EPS Diluted

$0.00

— vs Q2 2012

Gross Profit$5,728−55.8%

Operating Income

Same quarter

Metric	Q2 2013	Q2 2012	Q2 2011	Q2 2010
Revenue	$20.30K	$16.30K	$279.18K	$157.70K
Net Income	-$609.15K	-$134.27K	-$598.05K	-$1.35M
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR